Behind any landmark cure is years of medical research. But the old goal of research – to find a one-size-fits-all treatment for a disease, based on a set of standard protocols – must radically change to further and diversify advances in the field....
Precision medicine is arguably ‘the next big thing’ in modern medicine. Various initiatives, including the "All of Us" Research Program, have been launched and have gathered huge steam and funding in a bid to allow precise medical treatments that will in turn increase treatment success and decrease money lost owing to failures....
Black and Hispanic Americans are especially vulnerable to Alzheimer's. Yet they're often underrepresented in scientific studies of the disease....
Aaron Perry’s lifelong crusade to improve black men’s health and to crush racial disparities in so many different health-related categories is well-known here in Madison, but he's about to take things global. Mr. Perry is a member of the Community Advisory Board for the "All of Us" Research Program at UW-Madison. ...
The UW South Madison Partnership is moving into expanded space to support current and future growth as an important community resource....
Dr. Robert Golden, dean of the University of Wisconsin School of Medicine and Public Health discusses why he joined the All of Us Research Program and why this effort is so important to the future of health and health care in Wisconsin and beyond....
In recent years, genomics and genetic data have emerged as an innovative area of research that could potentially transform healthcare. This information could accelerate precision medicine, paving the way for individualized therapies tailored to each person....
Prasun Mishra, founding President and CEO of the American Association for Precision Medicine (AAPM) says the demise of his elder sister to pancreatic cancer led him to this work to create awareness about precision (or personalized) medicine....
New genetic guidelines include several updates—including new and expanded sections on risk assessment and management related to three major cancer types and also maintaining a more conservative approach toward testing practices where the evidence is still lacking....
If DNA is one important factor in our quest for more effective medical treatment, we need to address the lack of diversity in genetic data. That is where the "All of Us" Research Program comes into play....